![](/img/cover-not-exists.png)
Phase I Trial of Rosiglitazone in FSGS: I. Report of the FONT Study Group
Joy, M. S., Gipson, D. S., Dike, M., Powell, L., Thompson, A., Vento, S., Eddy, A., Fogo, A. B., Kopp, J. B., Cattran, D., Trachtman, H.Volume:
4
Language:
english
Journal:
Clinical Journal of the American Society of Nephrology
DOI:
10.2215/CJN.02310508
Date:
January, 2009
File:
PDF, 184 KB
english, 2009